HIF1A and facioscapulohumeral muscular dystrophy: From a therapeutic perspective, Lek et al. [39] showed that pharmacological HIF1α signaling inhibitors could improve DUX4-associated toxicity in myoblast cultures and muscle phenotypes in FSHD-like zebrafish embryos.